カテゴリー： GlobalData, 医療/バイオ, 日本

日本の遺伝子検査市場動向（～2021）

【英語タイトル】Japan Genetic Testing Market Outlook to 2021

GlobalDataが出版した調査資料（GDMECC1251DB）・商品コード：GDMECC1251DB
・発行会社（調査会社）：GlobalData
・発行日：2015年10月1日
・ページ数：28
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：日本
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥260,000見積依頼/購入/質問フォーム
Site License（同一国内共有可）USD5,000 ⇒換算￥520,000見積依頼/購入/質問フォーム
Enterprisewide License（複数国内共有可）USD7,500 ⇒換算￥780,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
【レポートの概要】

Japan Genetic Testing Market Outlook to 2021

Summary

GlobalData’s new report, “Japan Genetic Testing Market Outlook to 2021″, provides key market data on the Japan Genetic Testing market. The report provides value, in millions of US dollars within market segments – Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the Japan Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Genetic Testing Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Genetic Testing Market, Japan 7
3.1 Genetic Testing Market, Japan, Revenue ($m), 2007-2014 7
3.2 Genetic Testing Market, Japan, Revenue ($m), 2014-2021 9
3.3 Genetic Testing Market, Japan, Distribution Share by Revenue ($m), 2013-2014 11
3.4 Genetic Testing Market, Japan, Company Share by Revenue ($m), 2014 12
4 Overview of Key Companies in Japan, Genetic Testing Market 14
4.1 F. Hoffmann-La Roche Ltd. 14
4.1.1 Company Overview 14
4.2 Hologic, Inc. 14
4.2.1 Company Overview 14
4.3 Abbott Laboratories 14
4.3.1 Company Overview 14
4.4 Qiagen N.V. 15
4.4.1 Company Overview 15
4.5 Siemens Healthcare 15
4.5.1 Company Overview 15
4.6 PerkinElmer, Inc. 15
4.6.1 Company Overview 15
4.7 Transgenomic, Inc. 16
4.7.1 Company Overview 16
4.8 Fujirebio Europe N.V. 16
4.8.1 Company Overview 16
4.9 Danaher Corporation 16
4.9.1 Company Overview 16
4.10 Bio-Rad Laboratories, Inc. 17
4.10.1 Company Overview 17
4.11 Nuclear Laser Medicine srl 17
4.11.1 Company Overview 17
5 Genetic Testing Market Pipeline Products 18
6 Financial Deals Landscape 22
6.1 Asset Transactions 22
6.1.1 Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 22
6.2 Partnerships 24
6.2.1 Genomic Vision Extends Agreement with Quest Diagnostics 24
7 Appendix 25
7.1 Research Methodology 26
7.1.1 Coverage 26
7.1.2 Secondary Research 26
7.1.3 Primary Research 26
7.1.4 Company Share Analysis 27
7.1.5 Distribution Share Analysis 27
7.2 GlobalData Consulting 27
7.3 Contact Us 27
7.4 Disclaimer 28

1.1 List of Tables
Table 1: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Genetic Testing Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 11
Table 4: Genetic Testing Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 13
Table 5: Genetic Testing Market Pipeline Products 18
Table 6: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 22
Table 7: Genomic Vision Extends Agreement with Quest Diagnostics 24

1.2 List of Figures
Figure 1: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Genetic Testing Market, Japan, Company Share (%) 2014 12

【掲載企業】

F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Abbott Laboratories
Qiagen N.V.
Siemens Healthcare
PerkinElmer, Inc.
Transgenomic, Inc.
Fujirebio Europe N.V.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Nuclear Laser Medicine srl

★調査レポート[日本の遺伝子検査市場動向（～2021）] (コード：GDMECC1251DB)販売に関する免責事項を必ずご確認ください。
★調査レポート[日本の遺伝子検査市場動向（～2021）]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆